|
ZNF292 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.973200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.406560E-01 |
| Normal-vs-Stage2 |
6.370200E-01 |
| Normal-vs-Stage3 |
8.220200E-01 |
| Normal-vs-Stage4 |
7.082000E-01 |
| Stage1-vs-Stage2 |
7.400600E-01 |
| Stage1-vs-Stage3 |
4.812400E-01 |
| Stage1-vs-Stage4 |
4.329200E-01 |
| Stage2-vs-Stage3 |
8.238600E-01 |
| Stage2-vs-Stage4 |
5.161600E-01 |
| Stage3-vs-Stage4 |
5.942200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.366200E-01 |
| Normal-vs-AfricanAmerican |
9.834200E-01 |
| Normal-vs-Asian |
1.43200000002341E-06 |
| Caucasian-vs-AfricanAmerican |
3.508600E-01 |
| Caucasian-vs-Asian |
3.12449999984032E-07 |
| AfricanAmerican-vs-Asian |
6.37259999999307E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.198000E-02 |
| Normal-vs-Female |
1.549170E-01 |
| Male-vs-Female |
4.584000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.325800E-01 |
| Normal-vs-Extreme_Weight |
1.722720E-03 |
| Normal-vs-Obese |
8.548000E-01 |
| Normal-vs-Extreme_Obese |
7.048400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.001700E-02 |
| Normal_Weight-vs-Obese |
9.567000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.350600E-01 |
| Extreme_Weight-vs-Obese |
2.378400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.470400E-01 |
| Obese-vs-Extreme_Obese |
6.520400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.388000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.849600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.824400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.781990E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.152400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.187800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.496500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.697100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.699700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.569050E-01 |
| Normal-VS-Type2 PRCC |
1.455010E-01 |
| Normal-VS-KIRP CIMP |
5.541200E-01 |
| Normal-VS-Unclassified PRCC |
8.956200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.313800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.403600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.108600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.103200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.360800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.330800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.998500E-03 |
| Normal-vs-N1 |
1.421150E-01 |
| Normal-vs-N2 |
1.953560E-01 |
| N0-vs-N1 |
1.094400E-02 |
| N0-vs-N2 |
8.644000E-01 |
| N1-vs-N2 |
2.957600E-02 |
|
|
